LitAlert ~~ GeneLit.com

    • Concerns of Hereditary Breast Cancer in Pregnancy and Lactation.
    • Chen J, Prasath V, Axilbund J, Habibi M.
    • Adv Exp Med Biol. 2020;1252:129-132. doi: 10.1007/978-3-030-41596-9_17. [First Online: 2020 Aug 21.]
    • Book chapter
    • Poly (ADP-ribose) polymerase (PARP) inhibitor regimens for ovarian cancer in phase III randomized controlled trials: a network meta-analysis.
    • Gong H, Nie D, Huang Y, Li Z.
    • Int J Gynecol Cancer. 2020 Aug 19:ijgc-2020-001373. doi: 10.1136/ijgc-2020-001373. Epub ahead of print.
    • PARP inhibitors in ovarian cancer: evidence for maintenance and treatment strategies.
    • Bahena-González A, Toledo-Leyva A, Gallardo-Rincón D.
    • Chin Clin Oncol. 2020 Aug 14:cco-20-69. doi: 10.21037/cco-20-69. Epub ahead of print.
    • A preclinical trial and molecularly-annotated patient cohort identify predictive biomarkers in homologous recombination deficient pancreatic cancer.
    • Wang Y, Park JYP, Pacis A, Denroche RE, Jang GH, Zhang A, Cuggia A, Domecq C, Monlong J, Raitses-Gurevich M, Grant RC, Borgida A, Holter S, Stossel C, Bu S, Masoomian M, Lungu IM, Bartlett JMS, Wilson JM, Gao ZH, Riazalhosseini Y, Asselah J, Bouganim N, Cabrera T, Boucher LM, Valenti D, Biagi J, Greenwood CM, Polak P, Foulkes WD, Golan T, O'Kane GM, Fischer SE, Knox JJ, Gallinger S, Zogopoulos G.
    • Clin Cancer Res. 2020 Aug 14:clincanres.1439.2020. doi: 10.1158/1078-0432.CCR-20-1439. Epub ahead of print.
    • How I treat pancreatic cancer.
    • Taieb J, Abdallah R.
    • ESMO Open. 2020 Aug;4(Suppl 2):e000818. doi: 10.1136/esmoopen-2020-000818.